IP Library Granted Patent US 12,630,524
Granted Patent B2
US 12,630,524 · App. 17/919,204 · Granted May 19, 2026

Pleuromutilin in derivatives for treating viral infections

Inventors: Susanne Paukner (Vienna, AT); Rosemarie Riedl (Vienna, AT); Wolfgang Wicha (Bruck an der Leitha, AT)
Assignee: ARIVA MED GMBH
C07D401/12A61P31/04A61P31/14C07D241/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,630,524
App. No.
17/919,204
Granted
May 19, 2026
Kind
B2
Abstract

A compound selected from 14-O-[((Alkyl-, cycloalkyl-, heterocycloalkyl-, heteroaryl-, or aryl)-sulfanyl)-acetyl]-12-epi-mutilins, or 14-O-[((Alkyl-, cycloalkyl-, heterocycloalkyl-, heteroaryl-, or aryl)-oxy)-acetyl]-12-epi-mutilins, wherein 12-epi-mutilin is characterized in that the mutilin ring at position 12 is substituted by two substituents, the first substituent at position 12 of the mutilin ring is a methyl group which methyl group has the inverse stereochemistry compared with the stereochemistry of the methyl group at position 12 of the naturally occurring pleuromutilin ring, the second substituent at position 12 of the mutilin ring is a hydrocarbon group comprising at least one nitrogen atom and all other substituents of the mutilin ring having the same stereochemistry compared with the stereochemistry of the substituents at the corresponding positions in the naturally occurring pleuromutilin ring; optionally in the form of a pharmaceutically acceptable salt and/or solvate, prodrug or metabolite, wherein the naturally occurring pleuromutilin is of formula. for the specific use in the treatment or prevention of a disease mediated by a virus. The invention further relates to 12-epi-12-desvinyl-14-O-[(Piperidin-4-ylsulfanyl]-acetyl]-12-[2-(3-methyl-pyrazin-2-yl)-ethenyl]-mutilin and its therapeutic uses.

Claims (287)

1 . A compound of formula (II)

or a pharmaceutically acceptable salt or solvate thereof.

2 . A pharmaceutical composition comprising a compound of claim 1 or the pharmaceutically acceptable salt or solvate thereof, with at least one pharmaceutical excipient, optionally further comprising another pharmaceutically active agent.

3 . A method of treating or preventing a viral infection comprising administering to a subject in need thereof a compound of claim 1 or the pharmaceutically acceptable salt or solvate thereof.

4 . The method according to claim 3 , wherein the viral infection relates to a respiratory disease.

5 . The method according to claim 3 , wherein the viral infection relates to an acute respiratory syndrome optionally including Influenza, Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS) or COVID-19.

6 . The method according to claim 3 , wherein the viral infection is associated with a virus being a positive- or negative-sense single-stranded RNA virus, optionally the virus is

Coronaviridae, optionally including human coronavirus,

Paramyxoviridae, optionally including Paramyxovirinae, optionally including Measles virus, or Pneumovirinae, optionally including Respiratory Syncytial Virus,

Orthomyxoviridae, optionally including Influenza virus,

Flaviviridae, optionally including Dengue virus or Zika virus, or

Picornaviridae, optionally including Rhinovirus.

7 . The method according to claim 3 , wherein the viral infection relates to an airborne disease.

8 . A method for treating or preventing a viral infection, comprising administering to a subject in need thereof a compound of formula (I)

wherein R 1 is (C 1-16 )alkyl or (C 2-16 )alkenyl substituted by heterocyclyl including aliphatic and aromatic heterocyclyl and comprising 1 to 4 heteroatoms selected from N, O, and S, provided that at least one heteroatom is a nitrogen atom, or R 1 is

wherein Y—N(R 3 R 4 ) is

(C 1-16 )alkyl-N(R 3 R 4 ),

(C 1-16 )alkyl-(C 6-14 )aryl-N(R 3 R 4 ),

(C 1-16 )alkyl-(C 6-14 )aryl-(C 1-16 )alkyl-N(R 3 R 4 ),

(C 1-16 )alkyl-(C 1-13 )heterocyclyl-N(R 3 R 4 ),

(C 1-16 )alkyl-(C 1-13 )heterocyclyl-(C 1-16 )alkyl-N(R 3 R 4 ),

carbonyl-N(R 3 R 4 ),

(C 1-4 )alkyl-carbonyl-N(R 3 R 4 ),

(C 2-16 )alkenyl-N(R 3 R 4 ),

(C 2-16 )alkenyl-(C 6-14 )aryl-N(R 3 R 4 ),

(C 2-16 )alkenyl-(C 6-14 )aryl-(C 1-16 )alkyl-N(R 3 R 4 ),

(C 2-16 )alkenyl-(C 1-13 )heterocyclyl-N(R 3 R 4 ), or

(C 2-16 )alkenyl-(C 1-13 )heterocyclyl-(C 1-16 )alkyl-N(R 3 R 4 ),

wherein heterocyclyl includes aliphatic and aromatic heterocyclyl and comprises at least one heteroatom selected from N, O, and S, and

wherein alkyl, aryl, heterocyclyl, or alkenyl is optionally substituted by one or more substituents optionally having one or more heteroatoms selected from O, N, S, and halogen;

wherein each of R 3 and R 4 is independently

hydrogen,

(C 1-16 )alkyl,

(C 2-16 )alkenyl,

hydroxy-(C 1-16 )alkyl,

amino-(C 1-16 )alkyl,

mono- or di-(C 1-6 )alkylamino(C 1-16 )alkyl,

guanidino (C 1-16 )alkyl, ureido (C 1-16 )alkyl, or thioureido (C 1 -16)alkyl,

amino (C 1-6 )alkyl-(C 6-14 )aryl-(C 1-6 )alkyl,

amino(C 1-6 )alkyl-(C 6-14 )aryl,

guanidino (C 1-6 )alkyl-(C 6-14 )aryl-(C 1-6 )alkyl,

amino(C 1-6 )alkyloxy-(C 1-6 )alkyl,

amino(C 3-8 ) cycloalkyl,

amino(C 1-6 )alkyl-(C 3-8 ) cycloalkyl,

amino(C 3-8 ) cycloalkyl-(C 1-6 )alkyl,

amino(C 1-6 )alkyl-(C 3-8 ) cycloalkyl-(C 1-6 )alkyl,

(C 1-13 )heterocyclyl-(C 1-16 )alkyl,

(C 6-14 )aryl-(C 1-16 )alkyl,

(C 1-13 )heterocyclyl,

amino(C 6-14 )aryl-(C 1-16 )alkyl,

amino(C 1-6 )alkyloxy-(C 6-14 )aryl-(C 1-6 )alkyl,

amino(C 1-6 )alkyl-(C 6-12 )aryl-carbonyl,

amino(C 1-6 )alkyl-amido-(C 6-12 )aryl(C 1-6 )alkyl,

(C 1-4 )alkylcarbonyl, or

carbamimidoyl, carbamoyl, or thiocarbamoyl,

wherein heterocyclyl includes aliphatic and aromatic heterocyclyl and comprises at least one heteroatom selected from N, O, and S, and

wherein alkyl, cycloalkyl, heterocyclyl, alkenyl, or aryl is optionally substituted by

amino(C 1-4 )alkyl, amido, mono- or di-(C 1-4 )alkyl-amido, (C 1-6 )alkyloxy-carbonyl, halogen, oxo, or hydroxy,

wherein X is sulfur or oxygen, and

wherein R 2 is a hydrocarbon group comprising 1 to 22 carbon atoms, optionally comprising heteroatoms selected from N, O, S, and halogen, or a pharmaceutically acceptable salt or solvate, thereof.

9 . The method according to claim 8 , wherein, in the compound or the pharmaceutically acceptable salt or solvate, thereof, R 2 is

(C 1-16 )alkyl,

(C 3-12 ) cycloalkyl,

(C 1-13 )heterocyclyl, or

(C 6-14 )aryl,

wherein heterocyclyl includes aliphatic and aromatic heterocyclyl and comprises at least one heteroatom selected from N, O, and S, and

wherein alkyl, cycloalkyl, aryl, heterocyclyl is optionally substituted by one or more substituents having one or more heteroatoms selected from O, N, S, and halogen.

10 . The method according to claim 9 , wherein, in the compound or the pharmaceutically acceptable salt or solvate thereof, R 2 is

(C 1-16 )alkyl, optionally substituted by

hydroxy or amino,

(C 3-12 ) cycloalkyl optionally substituted by amino or amino(C 1-4 )alkyl, the amino or amino(C 1-4 )alkyl optionally further substituted by amino(C 1-6 )alkylcarbonyl or (C 1-4 )alkyl,

(C 2-11 )heterocyclyl having at least one nitrogen heteroatom and being optionally further substituted by amino(C 1-6 )alkylcarbonyl;

R 2 is cycloalkyl, optionally substituted by

amino(C 1-4 )alkyl, wherein amino is optionally further substituted by amino(C 1-6 )alkylcarbonyl,

hydroxy,

amino optionally substituted by amino(C 1-6 )alkylcarbonyl or (C 1-4 )alkyl,

amino and hydroxy, wherein amino is optionally further substituted by amino(C 1-6 )alkylcarbonyl or (C 1-4 )alkyl,

(C 1-4 )alkylamino optionally further substituted by one or more halogen atoms;

R 2 is aliphatic (C 2-11 )heterocyclyl comprising 1 to 4 heteroatoms selected from N, O, and S, wherein a nitrogen heteroatom is optionally substituted by

(C 1-4 )alkyl, or

amino(C 1-6 )alkylcarbonyl;

R 2 is aryl optionally substituted by

hydroxy, halogen, amino, hydroxy (C 1-4 )alkyl, bis-(hydroxy (C 1-4 )alkyl), amino(C 1-4 )alkyl, bis-(amino(C 1-4 )alkyl), wherein amino in amino(C 1-4 )alkyl is optionally further substituted,

(C 1-6 )alkyl optionally substituted by aminocarbonyl, wherein the nitrogen of the aminocarbonyl group is optionally further substituted by amino(C 1-12 )alkyl, diamino-(C 1-12 )alkyl, bis-(amino(C 1-12 )alkyl), hydroxy (C 1-6 )alkyl, bis-(hydroxy (C 1-6 )alkyl),

acylated amino(C 1-4 )alkyl,

aminocarbonyl, wherein nitrogen is optionally further substituted by amino(C 1-12 )alkyl, bis-(amino(C 1-12 )alkyl), hydroxy (C 1-6 )alkyl,

bis-(hydroxy (C 1-6 )alkyl), diamino(C 1-6 )alkyl, or

(C 1-12 )alkyl, optionally further substituted by

amino, optionally further substituted by formyl,

(C 1-4 )alkylcarbonyl, a 4- to 8-membered saturated or unsaturated heterocyclyl comprising 1 to 3 heteroatoms selected from N, O, and S, or (C 6-14 )aryl optionally further substituted by amino(C 1-4 )alkyl

or wherein nitrogen is part of (C 3-8 )heterocyclyl, including aliphatic and aromatic heterocyclyl, comprising one or more heteroatoms selected from N, O, S and being optionally further substituted by amino(C 1-4 )alkyl; or

R 2 is aromatic (C 1-13 )heterocyclyl comprising 1 to 4 heteroatoms and being optionally substituted by (C 1-6 )alkyl, amino, or hydroxy, wherein alkyl is optionally further substituted by halogen or amino, or being optionally substituted by aminocarbonyl,

wherein amino is optionally further substituted by amino(C 1-12 )alkyl, bis-(amino(C 1 -12)alkyl), hydroxy (C 1-6 )alkyl, bis-(hydroxy (C 1-6 )alkyl), or diamino(C 1-6 )alkyl.

11 . The method according to claim 8 , wherein, in the compound or the pharmaceutically acceptable salt or solvate thereof, R 2 is amido-phenyl, amido (C 1-4 )alkyl-phenyl, wherein nitrogen of amido is optionally substituted by amino(C 1-8 )alkyl, wherein alkyl is optionally further substituted.

12 . The method according to claim 8 , wherein, in the compound or the pharmaceutically acceptable salt or solvate thereof, R 2 is

amino(C 3-12 ) cycloalkyl,

amino(C 1-4 )alkyl(C 3-12 ) cycloalkyl,

amino(C 3-12 ) cycloalkyl(C 1-4 )alkyl, or

amino(C 1-4 )alkyl(C 3-12 ) cycloalkyl(C 1-4 )alkyl,

wherein amino is optionally substituted by amino(C 1-6 )alkylcarbonyl or (C 1-4 )alkyl.

13 . The method according to claim 8 , wherein, in the compound or the pharmaceutically acceptable salt or solvate thereof, R 2 is (C 2-11 )heterocyclyl comprising 1 to 4 heteroatoms selected from N, O, S, wherein, if R 2 has at least one nitrogen heteroatom, the at least one nitrogen heteroatom is optionally substituted by

(C 1-4 )alkyl, or

amino(C 1-6 )alkylcarbonyl.

14 . The method according to claim 8 , wherein, in the compound or the pharmaceutically acceptable salt or solvate thereof,

X is S, and

R 2 is

aminoethyl-amidomethyl-phenyl, aminopropyl-amidomethyl-phenyl, hydroxyphenyl-(amino)ethyl-amidomethyl-phenyl, aminomethyl-phenyl-(amino)ethyl-amidomethyl-phenyl, aminopropyl-amidophenyl, aminomethyl-phenylmethyl-amido-phenyl, aminomethyl-phenyl, aminoacetyl-aminomethyl-phenyl, bis(aminomethyl)phenyl, bisaminopropyl-amidomethyl-phenyl, (2-amino)-aminopropyl-amidomethyl-phenyl, aminoethyl-aminomethyl-phenyl, aminopropyl-aminomethyl-phenyl, allyl-aminomethyl-phenyl, aminomethyl-phenylmethyl-aminomethyl-phenyl, hydroxymethyl-phenyl, bis(hydroxymethyl)-phenyl, (tetrafluoro-hydroxymethyl)-phenyl, amino-hydroxy-cyclohexyl, hydroxyethyl, aminoethyl, piperazinocarbonyl-phenyl, aminomethyl-piperidine-carbonyl-phenyl, piperidine-ylmethyl-amido-phenyl, pyridine-ylmethyl-amido-phenyl, acetyl-aminopropyl-amido-phenyl, formyl-aminopropyl-amido-phenyl, amido-phenyl, aminohexyl-amidophenyl, aminoethyl-amidophenyl, (5-Amino)-4H-[1,2,4]triazol-3-yl, pyridinyl, hydroxyphenyl, fluorophenyl, purinyl, aminophenyl, acetyl-aminomethyl-phenyl, cyclopropyl-aminomethyl-phenyl, aminopropyl-amidopyridinyl, hydroxypropyl-amidophenyl, amino-purinyl, difluoroethylamino-cyclohexyl, amino-hydroxy-cyclohexyl, azepanyl, aminomethylcyclohexylmethyl, N-methyl-piperidinyl, piperidinyl, aminomethylcyclohexyl, aminopropylphenyl, phenyl, N-aminomethylcarbonyl-piperidinyl, N-aminoethylcarbonyl-piperidinyl, N-aminomethylcarbonyl-piperidinylmethyl, aminomethylamidomethylcyclohexyl, aminomethyl-pyridinyl, or aminomethylamidocyclohexyl.

15 . The method according to claim 8 , wherein the compound is of formula (III)

wherein

n is 1 to 12,

R 3 is H, aminoethyl, aminopropyl, aminobutyl, aminopentyl, aminohexyl, aminooctyl, aminodecyl, dimethylaminopropyl, dimethylamidopentyl, guanidinobutyl, guanidinohexyl, carbamimidoyl, aminomethylcyclohexylmethyl, aminopropoxypropyl, aminocyclohexyl, hydroxyhexyl, dihydroxypropyl, aminomethylphenylmethyl, guanidinomethylphenylmethyl, phenylmethyl, morpholinopropyl, piperidinyl, hexyl, pyridinylethyl, allyl, amido-benzyl, aminopropyl-amidobenzyl, (2-amino)-amidoethyl-benzyl, (2-amino)-dimethylamidoethyl-benzyl, 2-amino-1-aminomethyl-ethyl, 5-amino-5-ethoxycarbonyl-pentyl, aminomethylphenylpropyl, aminomethylphenyl, aminophenymethyl, aminoethoxyphenylmethyl, aminomethyl-fluorophenyl-methyl, or aminomethyl-difluorophenyl-methyl, and

R 4 is H, (C 1-4 )alkylcarbonyl, or aminomethylphenylcarbonyl

or a pharmaceutically acceptable salt or solvate, prodrug or metabolite thereof.

16 . The method according to claim 8 , wherein, in the compound or the pharmaceutically acceptable salt or solvate thereof,

R 1 is aminomethylphenylpropyl, aminoethylaminomethylphenylethenyl, aminoethylaminomethylphenylethyl, aminomethylphenylethyl, aminomethylphenylethyl, pyridinylethenyl, or aminoethylamino-fluorophenyl-ethenyl.

17 . The method according to claim 8 , wherein the compound or the pharmaceutically acceptable salt or solvate thereof is selected from

12-epi-12-desvinyl-14-O-{{4-[(3-Amino-propylcarbamoyl)-methyl]-phenylsulfanyl}-acetyl}-12-[(3-amino-propylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{{4-[(2-Amino-ethylcarbamoyl)-methyl]-phenylsulfanyl}-acetyl}-12-[(3-amino-propylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{{4-([Bis-(3-amino-propyl)-carbamoyl]-methyl}-phenylsulfanyl)-acetyl}-12-[(3-amino-propylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{{4-[(2,3-Diamino-propylcarbamoyl)-methyl]-phenylsulfanyl}-acetyl}-12-[(3-amino-propylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{{4-[(2-Amino-ethylcarbamoyl)-methyl]-phenylsulfanyl}-acetyl}-12-[(2-amino-ethylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{{4-[(3-Amino-propylcarbamoyl)-methyl]-phenylsulfanyl}-acetyl}-12-[(2-amino-ethylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{{4-[(3-Amino-propylcarbamoyl)-methyl]-phenylsulfanyl}-acetyl}-12-[(4-amino-butylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{{4-[(3-Amino-propylcarbamoyl)-methyl]-phenylsulfanyl}-acetyl}-12-[(5-amino-pentylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{{4-[(3-Amino-propylcarbamoyl)-methyl]-phenylsulfanyl}-acetyl}-12-[(4-aminomethyl-benzylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{{4-[(3-Amino-propylcarbamoyl)-methyl]-phenylsulfanyl}-acetyl}-12-[(6-amino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{{4-[(3-Amino-propylcarbamoyl)-methyl]-phenylsulfanyl}-acetyl}-12-[(6-guanidino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{{4-[(3-Amino-propylcarbamoyl)-methyl]-phenylsulfanyl}-acetyl}-12-[(4-guanidino-butylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{{4-[(3-Amino-propylcarbamoyl)-methyl]-phenylsulfanyl}-acetyl}-12-[(allylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{{4-[(3-Amino-propylcarbamoyl)-methyl]-phenylsulfanyl}-acetyl}-12-aminomethyl mutilin,

12-epi-12-desvinyl-14-O-{{4-[(3-Amino-propylcarbamoyl)-methyl]-phenylsulfanyl}-acetyl}-12-[(benzylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{{4-[(3-Amino-propylcarbamoyl)-methyl]-phenylsulfanyl}-acetyl}-12-[(4-guanidinomethyl-benzylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{{4-[(3-Amino-propylcarbamoyl)-methyl]-phenylsulfanyl}-acetyl}-12-[(6-hydroxy-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{{4-[(3-Amino-propylcarbamoyl)-methyl]-phenylsulfanyl}-acetyl}-12-[(2,3-dihydroxypropylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{{4-[(3-Amino-propylcarbamoyl)-methyl]-phenylsulfanyl}-acetyl}-12-[(4-piperidylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{{4-[(3-Amino-propylcarbamoyl)-methyl]-phenylsulfanyl}-acetyl}-12-[(3-morpholin-4-yl-propylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{{4-[(3-Amino-propylcarbamoyl)-methyl]-phenylsulfanyl}-acetyl}-12-[(3-dimethylamino-propylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{{4-[(3-Amino-propylcarbamoyl)-methyl]-phenylsulfanyl}-acetyl}-12-[(S)-5-amino-5-ethoxycarbonyl-pentylamino-methyl]mutilin,

12-epi-12-desvinyl-14-O-{[4-(4-Aminomethyl-benzylcarbamoyl)-phenylsulfanyl]-acetyl}-12-[(6-amino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{[4-(4-Aminomethylbenzylcarbamoyl)-phenylsulfanyl]-acetyl}-12-[(6-guanidino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{[(4-Piperazinylcarbamoyl)-phenylsulfanyl]-acetyl}-12-[(6-guanidino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{[4-(4-Aminomethyl-piperidine-1-carbonyl)-phenylsulfanyl]-acetyl}-12-[(6-guanidino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{(4-[(Piperidin-4-ylmethyl)-carbamoyl]-phenylsulfanyl)-acetyl}-12-[(6-guanidino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{(4-[(Pyridin-4-ylmethyl)-carbamoyl]-phenylsulfanyl)-acetyl}-12-[(6-amino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{[3-(3-Aminopropylcarbamoyl)-phenylsulfanyl]-acetyl}-12-[(6-guanidino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{[4-(3-Acetylamino-propylcarbamoyl)-phenylsulfanyl]-acetyl}-12-[(3-amino-propylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{[4-(3-Formylamino-propylcarbamoyl)-phenylsulfanyl]-acetyl}-12-[(3-amino-propylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{[4-(3-Amino-propylcarbamoyl)-phenylsulfanyl]-acetyl}-12-[(3-amino-propylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{(4-[(3-Aminopropylcarbamoyl)-phenylsulfanyl)-acetyl}-12-[(4-aminomethyl-benzylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{(4-[(3-Aminopropylcarbamoyl)-phenylsulfanyl)-acetyl}-12-[(6-amino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{[4-(3-Aminopropylcarbamoyl)-phenylsulfanyl]-acetyl}-12-[(6-guanidino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{[4-(3-Aminopropylcarbamoyl)-phenylsulfanyl]-acetyl}-12-[(8-amino-octylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{[4-(3-Aminopropylcarbamoyl)-phenylsulfanyl]-acetyl}-12-[(10-amino-decylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{(4-Carbamoyl-phenylsulfanyl)-acetyl}-12-[(6-guanidino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{[4-(3-Amino-propylcarbamoyl)-phenylsulfanyl]-acetyl}-12-{[3-(3-amino-propoxy)-propylamino)]-methyl}mutilin,

12-epi-12-desvinyl-14-O-{[4-(3-Amino-propylcarbamoyl)-phenylsulfanyl]-acetyl}-12 [(2-pyridin-4-yl-ethylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{[4-(6-Amino-hexylcarbamoyl)-phenylsulfanyl]-acetyl}-12-[(6-guanidino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{[4-(2-Amino-ethylcarbamoyl)-phenylsulfanyl]-acetyl}-12-[(6-guanidino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{[4-(3-Aminopropylcarbamoyl)-phenylsulfanyl]-acetyl}-12-{[3-(4-aminomethyl-phenyl)-propylamino]-methyl}mutilin,

12-epi-12-desvinyl-14-O-{[(4-Aminomethyl-cyclohexyl)-methylsulfanyl]-acetyl}-12-[(6-amino-hexylamino)-methyl]mutilin,

12-epi-14-O-[(1-Methyl-piperidin-4-ylsulfanyl)-acetyl}-12-[(6-guanidino-hexylamino)-methyl]mutilin,

12-epi-14-O-[(Piperidin-4-ylsulfanyl)-acetyl]-12-[(6-amino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{[(4-Aminomethyl-cyclohexyl)-sulfanyl]-acetyl}-12-[(6-amino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{[4-(3-Amino-propyl)-phenylsulfanyl]-acetyl}-12-[(6-amino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{(4-[(3-Amino-propylcarbamoyl)-methyl]-phenylsulfanyl)-acetyl}-12-{[(3-amino-propyl)-acetylamino]-methyl}mutilin,

12-epi-12-desvinyl-14-O-{(4-[(3-Amino-propylcarbamoyl)-methyl]-phenylsulfanyl)-acetyl}-12-(3-amino-propylcarbamoyl) mutilin,

12-epi-12-desvinyl-14-O-{[4-(3-Amino-propylcarbamoyl)-phenylsulfanyl]-acetyl}-12-(4-aminomethyl-benzylcarbamoyl) mutilin,

12-epi-12-desvinyl-14-O-{{4-[(3-Amino-propylcarbamoyl)-methyl]-phenylsulfanyl}-acetyl}-12-[2-(3-amino-propylamino)-ethyl]mutilin,

12-epi-12-desvinyl-14-O-[(3-Hydroxymethyl-phenylsulfanyl)-acetyl]-12-[(3-amino-propylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-[(3-Hydroxymethyl-phenylsulfanyl)-acetyl]-12-[(6-amino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-[(3-Hydroxymethyl-phenylsulfanyl)-acetyl]-12-[(4-aminomethyl-benzylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-[(3-Hydroxymethyl-phenylsulfanyl)-acetyl]-12-[(6-guanidino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-[(4-Hydroxymethyl-phenylsulfanyl)-acetyl]-12-[(3-amino-propylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-[(4-Hydroxymethyl-phenylsulfanyl)-acetyl]-12-[(4-aminomethyl-benzylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-[(4-Hydroxymethyl-phenylsulfanyl)-acetyl]-12-[(6-amino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-[(3,5-Bis-hydroxymethyl-phenylsulfanyl)-acetyl]-12-[(3-amino-propylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{[(2,3,5,6-Tetrafluoro-4-hydroxymethyl)-phenylsulfanyl]-acetyl}-12-[(4-aminomethyl-benzylamino)-methyl]-mutilin,

12-epi-12-desvinyl-14-O-{[(1R,2R,4R)-4-Amino-2-hydroxy-cyclohexylsulfanyl]-acetyl}-12-[(3-amino-propylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{[(1R,2R,4R)-4-Amino-2-hydroxy-cyclohexylsulfanyl]-acetyl}-12-[(4-aminomethyl-benzylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-[(2-Hydroxy-ethylsulfanyl)-acetyl]-12-[(4-aminomethyl-benzylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-[(2-Amino-ethylsulfanyl)-acetyl]-12-[(4-aminomethyl-benzylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{[(5-Amino-4H-1,2,4-triazol-3-yl)-sulfanyl]-acetyl}-12-[(6-amino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-[(2-Amino-ethylsulfanyl)-acetyl]-12-[(6-amino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-[(Pyridin-4-ylsulfanyl)-acetyl]-12-[(6-amino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-[(Pyridin-4-ylsulfanyl)-acetyl]-12-[(6-guanidino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-[(3-Hydroxy-phenylsulfanyl)-acetyl]-12-[(6-amino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-[(4-Fluoro-phenylsulfanyl)-acetyl]-12-[(6-amino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{[(7H-Purin-6-yl)-sulfanyl]-acetyl}-12-[(6-amino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-[(3-Amino-phenylsulfanyl)-acetyl]-12-[(3-amino-propylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-(Phenylsulfanyl-acetyl)-12-[(4-aminomethyl-benzylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-[(4-Fluoro-phenylsulfanyl)-acetyl]-12-[(4-aminomethyl-benzylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-[(Pyridin-2-ylsulfanyl)-acetyl]-12-[(4-aminomethyl-benzylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-[(Pyridin-4-ylsulfanyl)-acetyl]-12-[(4-aminomethyl-benzylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{[1-(2-Amino-acetyl)-piperidin-4-yl-sulfanyl)]-acetyl}-12-[(4-aminomethyl-benzylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{[1-(3-Amino-propionyl)-piperidin-4-yl-sulfanyl)]-acetyl}-12-[(4-aminomethyl-benzylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{[1-(3-Amino-propionyl)-piperidin-4-yl-sulfanyl]-acetyl}-12-[(6-amino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{[1-(2-Amino-acetyl)-piperidin-4-yl-methylsulfanyl]-acetyl}-12-[(4-aminomethyl-phenylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{[1-(2-Amino-acetyl)-piperidin-4-yl-methylsulfanyl]-acetyl}-12-[(4-amino-benzylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{[1-(2-Amino-acetyl)-piperidin-4-yl-sulfanyl]-acetyl}-12 {2-[4-(2-amino-ethoxy)-benzylamino]-methyl}mutilin,

12-epi-12-desvinyl-14-O-{{4-[(2-Amino-acetylamino)-methyl]-cyclohexylsulfanyl}-acetyl}-12-[{4-[(2-amino-ethoxy)-benzylamino]-methyl}mutilin,

12-epi-12-desvinyl-14-O-[(4-Aminomethyl-phenylsulfanyl)-acetyl]-12-[(3-amino-propylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-[(3-Aminomethyl-phenylsulfanyl)-acetyl]-12-[(3-amino-propylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-[(3-Aminomethyl-phenylsulfanyl)-acetyl]-12-[(6-guanidino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-[(4-Aminomethyl-phenylsulfanyl)-acetyl]-12-[(4-aminomethyl-benzylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-[(4-Aminomethyl-phenylsulfanyl)-acetyl]-12-[(6-amino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-[(3-Aminomethyl-phenylsulfanyl)-acetyl]-12-[((4-aminomethyl-cyclohexyl)-methylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-[(4-Aminomethyl-phenylsulfanyl)-acetyl]-12-{[(4-aminocyclohexyl)-amino]-methyl}mutilin,

12-epi-12-desvinyl-14-O-[(4-Aminomethyl-phenylsulfanyl)-acetyl]-12-[(hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-[(4-Aminomethyl-phenylsulfanyl)-acetyl]-12-[(4-carbamoylphenyl)-methylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-[(4-Aminomethyl-phenylsulfanyl)-acetyl]-12-{[4-(3-amino-propylcarbamoyl)-benzylamino]-methyl}mutilin,

12-epi-12-desvinyl-14-O-[(4-Aminomethyl-phenylsulfanyl)-acetyl]-12-[(5-dimethylcarbamoyl-pentylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-[(4-Aminomethyl-phenylsulfanyl)-acetyl]-12-{[4-(2-amino-2-carbamoyl-ethyl)-benzylamino]-methyl}mutilin,

12-epi-12-desvinyl-14-O-[(4-Aminomethyl-phenylsulfanyl)-acetyl]-12-{[4-(2-amino-2-dimethylcarbamoyl-ethyl)-benzylamino]-methyl}mutilin,

12-epi-12-desvinyl-14-O-{[5-Aminomethyl-pyridin-2-yl-sulfanyl)]-acetyl}-12-[(4-aminomethyl-benzylamino)-methyl]mutilin,

12-epi-12-Desvinyl-14-O-{[5-aminomethyl-pyridin-2-yl-sulfanyl)]-acetyl}-12-[(4-aminomethyl-3-fluoro-benzylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{[(4-Aminomethyl-cyclohexyl)-methylsulfanyl)-acetyl]{[(4-Aminomethyl-cyclohexyl)-methylsulfanyl]-acetyl}-12-[(4-aminomethyl-benzylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{1-(2-Amino-acetyl)-piperidin-4-yl-sulfanyl]-acetyl}-12-[(4-aminomethyl-3-fluoro-benzylamino)-methyl]mutilin,

12-epi-12-Desvinyl-14-O-{{4-[(2-Amino-acetylamino)-methyl]-cyclohexylsulfanyl}-acetyl}-12-[(4-aminomethyl-3-fluoro-benzylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{[5-Aminomethyl-pyridin-2-yl-sulfanyl]-acetyl}-12-[(4-aminomethyl-2,5-difluoro-benzylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-[(4-Aminomethyl-phenylsulfanyl)-acetyl]-12-[(2-amino-1-aminomethyl-ethylamino)-methyl]mutilin,

12-epi-12-Desvinyl-14-O-[(5-aminomethyl-pyridin-2-yl-sulfanyl)-acetyl]-12-[(6-amino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{(4-[(2-Amino-acetylamino)-methyl]-phenylsulfanyl)-acetyl}-12-[(3-amino-propylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{(4-[(2-Amino-3-(4-hydroxy-phenyl)-propionylamino)-methyl]-phenylsulfanyl)-acetyl}-12-[(3-amino-propylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{(4-[(3-Amino-propionylamino)-methyl]-phenylsulfanyl)-acetyl}-12-[(3-amino-propylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{(4-[(2-Amino-acetylamino)-methyl]-phenylsulfanyl)-acetyl}-12-[4-aminomethyl-benzylamino-methyl]mutilin,

12-epi-12-desvinyl-14-O-{(4-[(2-Amino-acetylamino)-methyl]-phenylsulfanyl)-acetyl}-12-(6-amino-hexylamino-methyl) mutilin,

12-epi-12-desvinyl-14-O-{[(3-Acetylamino-methyl)-phenylsulfanyl]-acetyl}-12-[(3-amino-propylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{(4-{[2-Amino-3-(4-aminomethyl-phenyl)-propionylamino]-methyl}-phenylsulfanyl)-acetyl}-12-[(3-amino-propylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{{4-[(3-Amino-propylamino)-methyl]-phenylsulfanyl}-acetyl}-12-[(3-amino-propylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{{3-[(3-Amino-propylamino)-methyl]-phenylsulfanyl}-acetyl}-12-[(3-amino-propylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{{4-[(4-Aminomethyl-benzylamino)-methyl]-phenylsulfanyl}-acetyl}-12-[(3-amino-propylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-[(3-Allylaminomethyl-phenylsulfanyl)-acetyl]-12-[(3-amino-propylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{{4-[(3-Amino-propylamino)-methyl]-phenylsulfanyl}-acetyl}-12-{[3-(3-amino-propoxy)-propylamino]-methyl}mutilin,

12-epi-12-desvinyl-14-O-[(4-Cyclopropylaminomethyl-phenylsulfanyl)-acetyl]-12-[(3-amino-propylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-[(4-Cyclopropylaminomethyl-phenylsulfanyl)-acetyl]-12-[(6-amino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{{4-[(4-Aminomethyl-benzylamino)-methyl]-phenylsulfanyl}-acetyl}-12-[(6-amino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{{4-[(4-Aminomethyl-benzylamino)-methyl]-phenylsulfanyl}-acetyl}-12-[(4-aminomethyl-benzylamino)-methyl]-mutilin,

12-epi-12-desvinyl-14-O-[5-(3-Amino-propylcarbamoyl)-pyridin-2-ylsulfanyl]-acetyl-12-[(6-amino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-[(2,5-Bis-aminomethyl-phenylsulfanyl)-acetyl]-12-[(3-amino-propylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-[(3,5-Bis-aminomethyl-phenylsulfanyl)-acetyl]-12-[(3-amino-propylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{[(3-Amino-propylcarbamoyl)-phenylsulfanyl]-acetyl}-12-[(2-guanidino-ethyl]mutilin,

12-epi-12-desvinyl-14-O-{[4-(3-Hydroxy-propylcarbamoyl)-phenylsulfanyl]-acetyl}-12-[(6-amino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-[(2-Hydroxy-ethylsulfanyl)-acetyl]-12-[(6-amino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{[3-(2,2-Difluoro-ethylamino)-cyclohexylsulfanyl]-acetyl}-12-[(6-amino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-[(2-Amino-7H-purin-6-ylsulfanyl)-acetyl]-12-[(6-amino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-[(Azepan-4-ylsulfanyl)-acetyl]-12-[(6-amino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-[(Azepan-4-ylsulfanyl)-acetyl]-12-[(6-guanidino-hexylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-[(Azepan-4-ylsulfanyl)-acetyl]-12-[(4-aminomethyl-benzylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-[(Azepan-4-ylsulfanyl)-acetyl]-12-[(6-amino-octylamino)-methyl]mutilin,

12-epi-12-desvinyl-14-O-{[1-(2-Amino-acetyl)-piperidin-4-yl-sulfanyl)]-acetyl}-12-[(6-amino-hexylamino)-ethyl]mutilin,

12-epi-12-desvinyl-14-O-{[1-(2-Amino-acetyl)-piperidin-4-yl-sulfanyl)]-acetyl}-12-[(4-aminomethyl-benzylamino)-ethyl]mutilin,

12-epi-12-desvinyl-14-O-[5-Hydroxymethyl-pyridin-2-yl-sulfanylacetyl]-12-[(4-aminomethyl-3-fluoro-benzylamino)-ethyl]mutilin,

12-epi-12-desvinyl-14-O-{4-[(2-Amino-acetylamino)-cyclohexylsulfanyl]-acetyl}-12-[(4-aminomethyl-3-fluoro-benzylamino)-ethyl]mutilin,

12-epi-12-desvinyl-14-O-{[1-(2-Amino-acetyl)-piperidin-4-yl-sulfanyl]-acetyl}-12-[(4-aminomethyl-3-fluoro-benzylamino)-ethyl]mutilin,

12-epi-12-desvinyl-14-O-[(5-Aminomethyl-pyridin-2-yl-sulfanyl)-acetyl]-12-[(4-aminomethyl-2,5-difluoro-benzylamino)-ethyl]mutilin,

12-epi-12-desvinyl-14-O-{[1-(2-Amino-acetyl)-piperidin-4-yl-sulfanyl]-acetyl}-12-[(4-aminomethyl-2,5-difluoro-benzylamino)-ethyl]mutilin,

12-epi-12-desvinyl-14-O-{[1-(2-Amino-acetyl)-piperidin-4-yl-sulfanyl]-acetyl}-12 {2-[4-(2-amino-ethoxy)-benzylamino]-ethyl}mutilin,

12-epi-12-desvinyl-14-O-{{4-[(2-Amino-acetylamino)-methyl]-cyclohexylsulfanyl}-acetyl}-12-[(4-aminomethyl-3-fluoro-benzylamino)-ethyl]mutilin,

12-epi-12-desvinyl-14-O-[(Azepan-4-ylsulfanyl)-acetyl]-12-[(4-aminomethyl-phenylamino)-ethyl]mutilin,

12-epi-12-desvinyl-14-O-{{4-[(2-Amino-acetylamino)]-cyclohexylsulfanyl}-acetyl}-12-[(4-aminomethyl-phenylamino)-ethyl]mutilin,

12-epi-12-desvinyl-14-O-{[1-(2-Amino-acetyl)-piperidin-4-yl-methylsulfanyl]-acetyl}-12-[(4-aminomethyl-phenylamino)-ethyl]mutilin,

12-epi-12-desvinyl-14-O-{[1-(2-Amino-acetyl)-piperidin-4-yl-sulfanyl]-acetyl}-12-(8-amino-octyl) mutilin,

12-epi-12-desvinyl-14-O-{[1-(2-Amino-acetyl)-piperidin-4-yl-sulfanyl]-acetyl}-12-[3-(4-aminomethyl-phenyl)-propyl]mutilin,

12-epi-12-desvinyl-14-O-[(Azepan-4-yl-sulfanyl)-acetyl]-12-[3-(4-aminomethyl-phenyl)-propyl]mutilin,

12-epi-12-desvinyl-14-O-[(Azepan-4-yl-sulfanyl)-acetyl]-12-(6-aminohexyl) mutilin,

12-epi-12-desvinyl-14-O-[(Azepan-4-yl-sulfanyl)-acetyl]-12-(8-amino-octyl) mutilin,

12-epi-12-desvinyl-14-O-{{4-[(2-Amino-acetylamino)-methyl]-cyclohexylsulfanyl}-acetyl}-12-[2-{4-[(2-amino-ethylamino)-methyl]-phenyl}-ethenyl) mutilin,

12-epi-12-desvinyl-14-O-{{4-[(2-Amino-acetylamino)-methyl]-cyclohexylsulfanyl}-acetyl}-12-[2-{4-[(2-amino-ethylamino)-methyl]-phenyl}-ethyl) mutilin,

12-epi-12-desvinyl-14-O-[(Azepan-4-ylsulfanyl)-acetyl]-12-[2-(4-Aminomethyl-phenyl)-ethyl]-mutilin,

12-epi-12-desvinyl-14-O-[(Azepan-4-ylsulfanyl)-acetyl]-12-((E)-2-pyridin-3-yl-ethenyl) mutilin,

12-epi-12-desvinyl-14-O-[(Azepan-4-ylsulfanyl)-acetyl]-12-((E)-2-{4-[(2-Amino-ethylamino)-methyl]-phenyl}-ethenyl) mutilin,

12-epi-12-desvinyl-14-O-[(Azepan-4-ylsulfanyl)-acetyl]-12-[2-{4-[(2-amino-ethylamino)-methyl]-phenyl}-ethyl) mutilin,

12-epi-12-desvinyl-14-O-[(Azepan-4-ylsulfanyl)-acetyl]-12-((E)-2-{4-[(2-amino-ethylamino)-methyl]-3-fluoro-phenyl}-ethenyl) mutilin,

12-epi-14-O-{[1-(2-Amino-acetyl)-piperidin-4-yl-sulfanyl]-acetyl}-12-((E)-2-{4-[(2-amino-ethylamino)-methyl]-phenyl}-ethenyl) mutilin,

12-epi-14-O-{[1-(2-Amino-acetyl)-piperidin-4-yl-sulfanyl]-acetyl}-12-[2-{4-[(2-amino-ethylamino)-methyl]-phenyl}-ethyl) mutilin,

12-epi-12-desvinyl-14-O-[(5-Aminomethyl-pyridin-2-ylsulfanyl)-acetyl]-12-[2-(4-aminomethyl-benzoylamino)-ethyl]mutilin,

12-epi-12-desvinyl-14-O-[(Piperidin-4-ylsulfanyl]-acetyl]-12-[2-(3-methyl-pyrazin-2-yl)-ethenyl]-mutilin, and their pharmaceutically acceptable salts or solvates.

18 . The method according to claim 8 , wherein the compound or the pharmaceutically acceptable salt or solvate thereof is 12-epi-12-desvinyl-14-O-[(Piperidin-4-ylsulfanyl]-acetyl]-12-[2-(3-methyl-pyrazin-2-yl)-ethenyl]-mutilin or its pharmaceutically acceptable salts or solvates.

19 . The method according to claim 8 , wherein the viral infection relates to a respiratory disease.

20 . The method according to claim 8 , wherein the viral infection relates to an acute respiratory syndrome optionally including Influenza, Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS) or COVID-19.

21 . The method according to claim 8 , the viral infection is associated with a virus being a positive- or negative-sense single-stranded RNA virus, optionally the virus is

Coronaviridae, optionally including human coronavirus,

Paramyxoviridae, optionally including Paramyxovirinae, optionally including Measles virus, or Pneumovirinae, optionally including Respiratory Syncytial Virus,

Orthomyxoviridae, optionally including Influenza virus,

Flaviviridae, optionally including Dengue virus or Zika virus, or

Picornaviridae, optionally including Rhinovirus.

22 . The method according to claim 8 , wherein the viral infection relates to an airborne disease.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 17, 2024
From: NABRIVA THERAPEUTICS GMBH
To: ARIVA MED GMBH
Reel/Frame 069613/0184 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 5, 2023
From: PAUKNER, SUSANNE; RIEDL, ROSEMARIE; WICHA, WOLFGANG
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 062280/0986 →
Priority Claims (1)
EP 20170074 · Apr 17, 2020 · regional
Continuity (1)
Related Publication 20230174509A1 · Jun 8, 2023
References Cited (26)
CN 103242210A · 2013 [cited by applicant]
CN 103204787B · 2014 [cited by applicant]
WO 2008113089A1 · 2008 [cited by applicant]
WO 2009106839A1 · 2009 [cited by applicant]
WO 2011146954A1 · 2011 [cited by applicant]
WO 2015110481A1 · 2015 [cited by applicant]
WO 2016202788A1 · 2016 [cited by applicant]
Lindsley et. al. “Distribution of Airborne Influenza Virus and Respiratory Syncytial Virus in an Urgent Care Medical Clinic” CID, 2010, 50, 5, 693-698. DOI: 10.1086/650457 (Year: 2010). [cited by examiner]
Tiamulin (CAS 55297-95-5) CAS Registry File Accessed Jun. 13, 2025 from STN, entered into STN Nov. 16, 1984 (Year: 1984). [cited by examiner]
Chen et al., “Preventive Effects of Valnemulin on Lipopolysaccharide-Induced Acute Lung Injury in Mice,” Inflammation, vol. 33, No. 5, pp. 306-314 (2010). [cited by applicant]
Berner et al., “Synthese ab-trans-anellierter derivate des tricyclischen diterpens pleuromutilin durch intramolekulare 1,5-hydrid-verschiebung,” Tetrahedron, vol. 36, pp. 1807-1811 (1980). [cited by applicant]
Hafner et al., “Anti-inflammatory activity of lefamulin versus azithromycin and dexamethasone in vivo and in vitro in a lipopolysaccharide-induced lung neutrophilia mouse model,” Plos One, https://doi.org/10.1371/journa… [cited by applicant]
Matthay et al., “The acute respiratory distress syndrome,” Journal of Clinical Investigation, vol. 122, No. 8, pp. 2731-2740 (2012). [cited by applicant]
Matute-Bello et al., “Animal models of acute lung injury,” American Journal of Physiology Lung Cellular and Molecular Physiology, vol. 295, No. 3, pp. L379-L399 (2008). [cited by applicant]
Giacalone et al., “Neutrophil Adaptations upon Recruitment to the Lung: New Concepts and Implications for Homeostasis and Disease,” International Journal of Molecular Sciences, vol. 21, 851, pp. 1-21 (2020). [cited by applicant]
Yu et al., “Itaconate: An emerging determinant of inflammation in activated macrophages,” Immunology & Cell Biology, vol. 97, pp. 134-141 (2019). [cited by applicant]
Liao et al., “4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to exert anti-inflammatory effects,” Nature Communications, vol. 10, No. 5091, pp. 1-11 (2019). [cited by applicant]
Long et al., “The Cfr rRNA Methyltransferase Confers Resistance to Phenicols, Lincosamides, Oxazolidinones, Pleuromutilins, and Streptogramin A Antibiotics,” Antimicrobial Agents and Chemotherapy, vol. 50, No. 7, pp. 25… [cited by applicant]
Mendes et al., “Low Prevalence of Gram-Positive Isolates Showing Elevated Lefamulin MIC Results during the SENTRY Surveillance Program for 2015-2016 and Characterization of Resistance Mechanisms,” Antimicrobial Agents a… [cited by applicant]
Q1 2020 Nabriva Therapeutics PLC Earnings Call of May 11, 2020, Press release (https://investors.nabriva.com/news-releases/news-release-details/nabriva-therapeutics-reports-first-quarter-2020-financial), downloaded May … [cited by applicant]
Alexander et al., “Oral Lefamulin vs Moxidloxacin for Early Clinical Response Among Adults with Community-Acquired Bacterial Pneumonia—The LEAP 2 Randomized Clinical Trial,” Journal of American Medical Association, vol.… [cited by applicant]
Zuo et al., “Antibacterial Activity and Pharmacokinetic Profile of a Promising Antibacterial Agent: 22-(2-Amino-phenylsulfanyl)-22-Deoxypleuromutilin,” Molecules, vol. 25, No. 878, pp. 1-13 (2020). [cited by applicant]
Asheshov, et al., “A Survey of Actinomycetes for Antiphage Activity,” Antibiotics & Chemotherapy, vol. 4, No. 4, pp. 380-394 (1954). [cited by applicant]
Alarcon, et al., “Screening for new compounds with anitherpes activity,” Antiviral Research, vol. 4, pp. 231-243 (1984). [cited by applicant]
“Pleuromutilin,” The Merck Index, 12th edition, Item 7694, p. 1298. [cited by applicant]
Zhang, et al., “Valnemulin downregulates nitric oxide, prostaglandin E2, and cytokine production via inhibition of NF-KB and MAPK activity,” International Immunopharmacology, vol. 9, pp. 810-816 (2009). [cited by applicant]